Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wouter Peelaerts

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Free Neuropathology|February 28, 2022
Inhibiting the mitochondrial pyruvate carrier does not ameliorate synucleinopathy in the absence of inflammation or metabolic deficitsWouter Peelaerts, Liza Bergkvist, Sonia George, et al.
Acta Neuropathologica Communications|January 24, 2026
Absence of Ledgf in mouse brain affects the Kmt2a/b and polycomb balance, synaptic transmission and motor functionLaura Debusschere, Eduard Bentea, Cecilia Iglesias-Herrero, et al.
Frontiers in Immunology|March 11, 2026
Generation and characterization of human induced pluripotent stem cells from neuropathologically confirmed multiple system atrophy patient-derived fibroblastsMireia Alemany-Ribes, Alexandra Pérez-Soriano, Almudena Santos, et al.
Journal of Parkinson'S Disease|February 13, 2021
T Cells Limit Accumulation of Aggregate Pathology Following Intrastriatal Injection of α-Synuclein FibrilsSonia George, Trevor Tyson, Nolwen L Rey, et al.
Acta Neuropathologica|March 29, 2023
Urinary tract infections trigger synucleinopathy via the innate immune responseWouter Peelaerts, Gabriela Mercado, Sonia George, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Free Neuropathology|February 28, 2022
Inhibiting the mitochondrial pyruvate carrier does not ameliorate synucleinopathy in the absence of inflammation or metabolic deficitsWouter Peelaerts, Liza Bergkvist, Sonia George, et al.
Acta Neuropathologica Communications|January 24, 2026
Absence of Ledgf in mouse brain affects the Kmt2a/b and polycomb balance, synaptic transmission and motor functionLaura Debusschere, Eduard Bentea, Cecilia Iglesias-Herrero, et al.
Frontiers in Immunology|March 11, 2026
Generation and characterization of human induced pluripotent stem cells from neuropathologically confirmed multiple system atrophy patient-derived fibroblastsMireia Alemany-Ribes, Alexandra Pérez-Soriano, Almudena Santos, et al.
Journal of Parkinson'S Disease|February 13, 2021
T Cells Limit Accumulation of Aggregate Pathology Following Intrastriatal Injection of α-Synuclein FibrilsSonia George, Trevor Tyson, Nolwen L Rey, et al.
Acta Neuropathologica|March 29, 2023
Urinary tract infections trigger synucleinopathy via the innate immune responseWouter Peelaerts, Gabriela Mercado, Sonia George, et al.
Pageof 2